Sexual health
PT-141 (Bremelanotide): Uses, Side Effects and Safety
Melanocortin receptor agonist; prescription medicine in the United States for a specific indication.
Overview
Bremelanotide is a peptide medicine with a narrow U.S. FDA-labeled use. It is not a general sexual-performance enhancer and its indication does not apply to all people.
How it works
It is a melanocortin receptor agonist. The FDA label describes the approved use and important limitations; mechanism alone does not predict individual benefit.
Uses described in the source
The cited 2019 U.S. label describes its use for premenopausal women with acquired, generalized hypoactive sexual desire disorder when the condition is not due to another medical or psychiatric condition, relationship problems, or medication effects. It is not indicated for men, postmenopausal women, or sexual-performance enhancement. The linked label may not be the latest; verify current information.
Evidence
Human trial evidence for a narrow, labeled indication
Regulatory status
The cited 2019 Vyleesi label is a U.S. FDA label for a specified indication and may not be the latest approved label. It does not establish approval or availability in Colombia, or availability through YouMedicine.
Safety
The label warns about temporary increases in blood pressure and decreases in heart rate, and contraindicates use with uncontrolled hypertension or known cardiovascular disease. Nausea and focal hyperpigmentation are also described.
YouMedicine availability
Educational listing only. YouMedicine availability has not been confirmed.
Sources
This product's indication is not a general claim about libido or sexual wellness. Review the current label and personal risks with a licensed clinician.